Article
Alternative splicing of BCL‑X and implications for treating hematological malignancies (Review)
18 Jul 2021
Abstract excerpt
BCL‑X is a member of the BCL‑2 family. It regulates apoptosis and plays a critical role in hematological malignancies. It is well‑known that >90% of human genes undergo alternative splicing. A total of 10 distinct splicing transcripts of the BCL‑X gene have been identified, including transcript variants 1‑9 and ABALON. Different transcripts from the same gene have different functions. The present review discusses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
